|
|
Huifeng Reports Progress on Diosmin Contract
publication date: Jul 30, 2008
Huifeng Bio-Pharmaceutical Technology announced it is on track to gain COS (European Certificate of Suitability) approval in September to provide Diosmin to Safic-Alcan, a French chemical company. Diosmin is a semisynthetic phlebotropic drug, a member of the flavonoid family that can be isolated from various plant sources or derived from the flavonoid hesperidin. It is used as a supplement to treat chronic venous insufficiency, hemorrhoids, lymphedema, and varicose veins. More details...
Stock Symbol: (OTCBB: HFGB)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|